These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 11976244

  • 1. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
    Chiba N, Van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E.
    BMJ; 2002 Apr 27; 324(7344):1012-6. PubMed ID: 11976244
    [Abstract] [Full Text] [Related]

  • 2. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.
    Chiba N, Veldhuyzen Van Zanten SJ, Escobedo S, Grace E, Lee J, Sinclair P, Barkun A, Armstrong D, Thomson AB.
    Aliment Pharmacol Ther; 2004 Feb 01; 19(3):349-58. PubMed ID: 14984382
    [Abstract] [Full Text] [Related]

  • 3. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
    Lane JA, Murray LJ, Noble S, Egger M, Harvey IM, Donovan JL, Nair P, Harvey RF.
    BMJ; 2006 Jan 28; 332(7535):199-204. PubMed ID: 16428249
    [Abstract] [Full Text] [Related]

  • 4. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ, Janssens J, Lauritsen K, Rácz I, Bolling-Sternevald E.
    BMJ; 1999 Mar 27; 318(7187):833-7. PubMed ID: 10092259
    [Abstract] [Full Text] [Related]

  • 5. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL, Talley NJ, O'Moráin C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberöd A, Theodórs A, Sundin M, Bolling-Sternevald E, Junghard O.
    N Engl J Med; 1998 Dec 24; 339(26):1875-81. PubMed ID: 9862942
    [Abstract] [Full Text] [Related]

  • 6. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
    Färkkilä M, Sarna S, Valtonen V, Sipponen P, PROSPER Study Group.
    Scand J Gastroenterol; 2004 Apr 24; 39(4):327-35. PubMed ID: 15125464
    [Abstract] [Full Text] [Related]

  • 7. [Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].
    Ruiz García A, Gordillo López FJ, Hermosa Hernán JC, Arranz Martínez E, Villares Rodríguez JE.
    Med Clin (Barc); 2005 Mar 26; 124(11):401-5. PubMed ID: 15799844
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: a prospective, long-term, follow-up, workplace outcome study.
    Madisch A, Hotz J, Grabowski G, Guth A, Malfertheiner P, Plein K, Schneider B.
    Eur J Gastroenterol Hepatol; 2002 Jan 26; 14(1):61-9. PubMed ID: 11782577
    [Abstract] [Full Text] [Related]

  • 9. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection.
    Gwee KA, Teng L, Wong RK, Ho KY, Sutedja DS, Yeoh KG.
    Eur J Gastroenterol Hepatol; 2009 Apr 26; 21(4):417-24. PubMed ID: 19369829
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH, Warbasse L, Brenner C.
    J Fam Pract; 1997 Jun 26; 44(6):545-55. PubMed ID: 9191627
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
    Romano M, Marmo R, Cuomo A, De Simone T, Mucherino C, Iovene MR, Montella F, Tufano MA, Del Vecchio Blanco C, Nardone G.
    Clin Gastroenterol Hepatol; 2003 Jul 26; 1(4):273-8. PubMed ID: 15017668
    [Abstract] [Full Text] [Related]

  • 12. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
    Veldhuyzen van Zanten S, Fedorak RN, Lambert J, Cohen L, Vanjaka A.
    Am J Gastroenterol; 2003 Sep 26; 98(9):1963-9. PubMed ID: 14499772
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J, Farkkilä M, Sipponen P.
    Am J Gastroenterol; 2001 Oct 26; 96(10):2866-72. PubMed ID: 11693319
    [Abstract] [Full Text] [Related]

  • 14. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T.
    N Engl J Med; 1998 Dec 24; 339(26):1869-74. PubMed ID: 9862941
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
    Liu Q, Qi D, Kang J, Jin Y, Liu W, Gao W, Hou P, Lu J.
    Eur J Gastroenterol Hepatol; 2015 Mar 24; 27(3):221-5. PubMed ID: 25629566
    [Abstract] [Full Text] [Related]

  • 16. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ, Vakil N, Ballard ED, Fennerty MB.
    N Engl J Med; 1999 Oct 07; 341(15):1106-11. PubMed ID: 10511608
    [Abstract] [Full Text] [Related]

  • 17. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
    Mason J, Axon AT, Forman D, Duffett S, Drummond M, Crocombe W, Feltbower R, Mason S, Brown J, Moayyedi P, Leeds HELP Study Group.
    Aliment Pharmacol Ther; 2002 Mar 07; 16(3):559-68. PubMed ID: 11876711
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori eradication in functional dyspepsia: HEROES trial.
    Mazzoleni LE, Sander GB, Francesconi CF, Mazzoleni F, Uchoa DM, De Bona LR, Milbradt TC, Von Reisswitz PS, Berwanger O, Bressel M, Edelweiss MI, Marini SS, Molina CG, Folador L, Lunkes RP, Heck R, Birkhan OA, Spindler BM, Katz N, Colombo Bda S, Guerrieri PP, Renck LB, Grando E, Hocevar de Moura B, Dahmer FD, Rauber J, Prolla JC.
    Arch Intern Med; 2011 Nov 28; 171(21):1929-36. PubMed ID: 22123802
    [Abstract] [Full Text] [Related]

  • 19. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP, Cruzado AI, Garcia-Gravalos R, Pajares JM.
    Hepatogastroenterology; 2004 Nov 28; 51(55):303-8. PubMed ID: 15011890
    [Abstract] [Full Text] [Related]

  • 20. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.
    Clin Ther; 2008 Mar 28; 30(3):528-34. PubMed ID: 18405790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.